1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Brubaker, K. Cowley, S.M. Huang, K. Eisenman, R.N. Radhakrishnan, I. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 103 655 665 10.1016/S0092-8674(00)00168-9 11106735 Solution structure of the interacting domains of the Mad-Sin3 complex: implications for recruitment of a chromatin-modifying complex. 2000 10.2210/pdb1g1e/pdb pdb_00001g1e 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1968.302 MAD1 PROTEIN SIN3 INTERACTION DOMAIN (SID) TRANSREPRESSION DOMAIN 1 syn polymer 10343.438 SIN3A PAIRED AMPHIPATHIC HELIX 2 (PAH2 REPEAT) 1 man polymer MAX DIMERIZATION PROTEIN no no RMNIQMLLEAADYLER RMNIQMLLEAADYLER A polypeptide(L) no no SLQNNQPVEFNHAINYVNKIKNRFQGQPDIYKAFLEILHTYQKEQRNAKEAGGNYTPALTEQEVYAQVARLFKNQEDLLS EFGQFLPDA SLQNNQPVEFNHAINYVNKIKNRFQGQPDIYKAFLEILHTYQKEQRNAKEAGGNYTPALTEQEVYAQVARLFKNQEDLLS EFGQFLPDA B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n house mouse Mus Escherichia sample 10090 Mus musculus 562 Escherichia coli PET24 database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2000-12-06 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name RCSB Y RCSB 2000-10-11 REL REL The peptide sequence was synthesized via automated methods. The sequence is naturally found in Homo sapiens (human). sample Interproton NOEs were assigned iteratively but manually during structure refinement. structures with favorable non-bond energy,structures with the least restraint violations 25 15 3D 15N-separated_NOESY HNHA 2D 13C,15N-double-half-filtered NOESY 2D 13C-double-half-filtered NOESY 3D 13C-separated_NOESY 3D HACAHB 2D Spin-echo Difference for JNCgamma, JC'Cgamma 3D HNHB 20 mM phosphate 6.0 ambient 300 K The structures are based on 1612 unique distance constraints, 198 torsion angle constraints and 72 JHNHA coupling constant constraints. distance geometry, simulated annealing 15 minimized average structure 1.0 mM 1:1 SID unlabeled, PAH2 U-15N; 1.6 mM 1:1 SID unlabeled, PAH2 U-15N, U-13C. 90% H2O/10% D2O 1.6 mM 1:1 SID unlabeled, PAH2 U-15N,13C; 20 mM phosphate buffer pH 6.0, 0.2% NaN3 90% H2O/10% D2O 1.6 mM 1:1 SID unlabeled, PAH2 U-15N,13C; 20 mM phosphate buffer pH 6.0, 0.2% NaN3 100% D2O Molecular Simulations processing Felix 98 Molecular Simulations data analysis Felix 98 Guntert, Wuthrich structure solution DYANA 1.5 Brunger refinement CNS 1.0 600 Varian INOVA 500 Varian INOVA ARG 6 n 1 ARG 6 A MET 7 n 2 MET 7 A ASN 8 n 3 ASN 8 A ILE 9 n 4 ILE 9 A GLN 10 n 5 GLN 10 A MET 11 n 6 MET 11 A LEU 12 n 7 LEU 12 A LEU 13 n 8 LEU 13 A GLU 14 n 9 GLU 14 A ALA 15 n 10 ALA 15 A ALA 16 n 11 ALA 16 A ASP 17 n 12 ASP 17 A TYR 18 n 13 TYR 18 A LEU 19 n 14 LEU 19 A GLU 20 n 15 GLU 20 A ARG 21 n 16 ARG 21 A SER 295 n 1 SER 295 B LEU 296 n 2 LEU 296 B GLN 297 n 3 GLN 297 B ASN 298 n 4 ASN 298 B ASN 299 n 5 ASN 299 B GLN 300 n 6 GLN 300 B PRO 301 n 7 PRO 301 B VAL 302 n 8 VAL 302 B GLU 303 n 9 GLU 303 B PHE 304 n 10 PHE 304 B ASN 305 n 11 ASN 305 B HIS 306 n 12 HIS 306 B ALA 307 n 13 ALA 307 B ILE 308 n 14 ILE 308 B ASN 309 n 15 ASN 309 B TYR 310 n 16 TYR 310 B VAL 311 n 17 VAL 311 B ASN 312 n 18 ASN 312 B LYS 313 n 19 LYS 313 B ILE 314 n 20 ILE 314 B LYS 315 n 21 LYS 315 B ASN 316 n 22 ASN 316 B ARG 317 n 23 ARG 317 B PHE 318 n 24 PHE 318 B GLN 319 n 25 GLN 319 B GLY 320 n 26 GLY 320 B GLN 321 n 27 GLN 321 B PRO 322 n 28 PRO 322 B ASP 323 n 29 ASP 323 B ILE 324 n 30 ILE 324 B TYR 325 n 31 TYR 325 B LYS 326 n 32 LYS 326 B ALA 327 n 33 ALA 327 B PHE 328 n 34 PHE 328 B LEU 329 n 35 LEU 329 B GLU 330 n 36 GLU 330 B ILE 331 n 37 ILE 331 B LEU 332 n 38 LEU 332 B HIS 333 n 39 HIS 333 B THR 334 n 40 THR 334 B TYR 335 n 41 TYR 335 B GLN 336 n 42 GLN 336 B LYS 337 n 43 LYS 337 B GLU 338 n 44 GLU 338 B GLN 339 n 45 GLN 339 B ARG 340 n 46 ARG 340 B ASN 341 n 47 ASN 341 B ALA 342 n 48 ALA 342 B LYS 343 n 49 LYS 343 B GLU 344 n 50 GLU 344 B ALA 345 n 51 ALA 345 B GLY 346 n 52 GLY 346 B GLY 347 n 53 GLY 347 B ASN 348 n 54 ASN 348 B TYR 349 n 55 TYR 349 B THR 350 n 56 THR 350 B PRO 351 n 57 PRO 351 B ALA 352 n 58 ALA 352 B LEU 353 n 59 LEU 353 B THR 354 n 60 THR 354 B GLU 355 n 61 GLU 355 B GLN 356 n 62 GLN 356 B GLU 357 n 63 GLU 357 B VAL 358 n 64 VAL 358 B TYR 359 n 65 TYR 359 B ALA 360 n 66 ALA 360 B GLN 361 n 67 GLN 361 B VAL 362 n 68 VAL 362 B ALA 363 n 69 ALA 363 B ARG 364 n 70 ARG 364 B LEU 365 n 71 LEU 365 B PHE 366 n 72 PHE 366 B LYS 367 n 73 LYS 367 B ASN 368 n 74 ASN 368 B GLN 369 n 75 GLN 369 B GLU 370 n 76 GLU 370 B ASP 371 n 77 ASP 371 B LEU 372 n 78 LEU 372 B LEU 373 n 79 LEU 373 B SER 374 n 80 SER 374 B GLU 375 n 81 GLU 375 B PHE 376 n 82 PHE 376 B GLY 377 n 83 GLY 377 B GLN 378 n 84 GLN 378 B PHE 379 n 85 PHE 379 B LEU 380 n 86 LEU 380 B PRO 381 n 87 PRO 381 B ASP 382 n 88 ASP 382 B ALA 383 n 89 ALA 383 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A O H MET MET 7 11 1.57 4 B B HH O TYR LEU 310 372 1.59 9 B B O H VAL LYS 311 315 1.59 9 A A O H ILE LEU 9 13 1.60 14 B B O H VAL LYS 311 315 1.60 2 -3.78 0.60 121.00 117.22 A A A CB CG CD2 TYR TYR TYR 18 18 18 N 1 A ASN 8 -7.09 -97.36 1 B GLN 300 57.06 85.71 1 B PHE 318 -98.93 39.85 1 B PHE 366 -90.38 43.98 1 B LYS 367 -51.70 -74.32 1 B GLN 369 -142.44 49.40 1 B ASP 382 -87.73 48.61 2 A MET 7 65.37 -179.82 2 A ASN 8 -84.33 -73.10 2 B LEU 296 65.18 89.53 2 B GLN 297 72.95 154.99 2 B ASN 298 67.31 152.79 2 B ASN 299 46.49 -168.84 2 B GLN 300 63.33 86.16 2 B PHE 318 -102.24 41.22 2 B GLN 321 -105.24 79.26 2 B PHE 366 -88.61 42.53 2 B GLN 369 -142.40 52.40 2 B PRO 381 -64.51 -159.66 3 A ASN 8 -126.67 -53.63 3 B GLN 297 76.54 -82.76 3 B ASN 298 -150.91 -26.96 3 B ASN 348 -83.43 33.68 3 B PRO 381 -68.81 7.46 3 B ASP 382 -89.63 31.61 4 A ASN 8 -176.02 -127.16 4 B ASN 298 -88.13 -78.46 4 B THR 350 66.89 127.56 4 B PHE 366 -91.56 41.81 4 B LYS 367 -49.64 -71.76 4 B ASN 368 -85.19 33.89 4 B PRO 381 -56.81 -155.33 5 A ASN 8 -147.83 -119.01 5 B LEU 296 61.68 99.39 5 B GLN 321 -103.87 79.34 5 B ASN 348 -83.90 32.66 5 B PHE 366 -88.40 -141.39 5 B LYS 367 113.69 -52.27 5 B GLN 369 -142.31 58.16 5 B PRO 381 -59.44 19.97 5 B ASP 382 67.51 -79.96 6 A MET 7 76.21 -20.26 6 B ASN 298 -149.81 -28.93 6 B GLN 300 68.86 137.90 6 B PHE 318 -96.99 38.46 6 B PHE 366 -90.53 41.03 6 B GLN 369 -142.72 53.38 6 B PRO 381 -62.36 -156.90 7 A ASN 8 -172.48 -129.95 7 B GLN 297 53.88 -170.58 7 B ASN 298 63.71 179.93 7 B ASN 299 -77.67 -166.36 7 B GLN 300 70.61 82.41 7 B PHE 318 -101.91 42.46 7 B GLN 321 -107.16 78.80 7 B TYR 349 -157.47 -51.26 7 B THR 350 61.91 131.27 7 B PHE 366 -90.33 32.29 7 B GLN 369 -142.37 58.95 7 B PRO 381 -66.05 12.39 8 A MET 7 68.23 99.60 8 A ASN 8 -84.73 -124.62 8 B GLN 297 -162.61 -45.64 8 B ASN 298 71.39 -73.44 8 B ASN 299 -159.09 -124.76 8 B PRO 301 -83.76 36.29 8 B PHE 318 -100.84 44.97 8 B ASN 348 -156.59 -47.74 8 B PHE 366 -90.99 51.43 8 B LYS 367 -51.96 -75.55 8 B ASN 368 -85.13 38.55 8 B GLN 369 -149.93 56.43 8 B PRO 381 -64.27 -159.10 9 A ASN 8 -103.44 -66.35 9 B GLN 300 67.03 156.97 9 B PHE 318 -99.60 39.57 9 B THR 350 64.04 132.54 9 B PHE 366 -94.89 36.26 9 B GLN 369 -142.70 48.90 9 B PRO 381 -74.66 -150.53 10 B LEU 296 -163.95 -52.13 10 B GLN 297 -162.73 -55.68 10 B ASN 298 60.77 95.14 10 B PHE 318 -99.54 33.80 10 B GLN 321 -105.97 75.84 10 B PHE 366 -88.62 47.94 10 B LYS 367 -50.86 -73.31 10 B GLN 369 -142.34 50.26 10 B PRO 381 -34.85 156.33 11 A ASN 8 -171.23 -95.14 11 B LEU 296 62.95 93.52 11 B ASN 298 -88.07 -78.64 11 B GLN 300 60.77 84.51 11 B PHE 318 -101.10 46.35 11 B GLN 321 -119.92 75.65 11 B ASN 348 -83.25 34.26 11 B TYR 349 -163.23 117.93 11 B PHE 366 -89.66 44.25 11 B GLN 369 -142.48 53.76 11 B PRO 381 -63.03 -158.80 12 A ILE 9 60.39 -59.17 12 B ASN 298 61.43 79.06 12 B PHE 318 -95.54 31.64 12 B TYR 349 -157.27 -60.19 12 B THR 350 61.94 133.48 12 B PHE 366 -89.20 47.09 12 B GLN 369 -142.42 47.50 13 A ASN 8 -135.70 -51.73 13 B GLN 297 84.87 -34.25 13 B ASN 298 69.54 133.12 13 B GLN 300 -154.76 81.10 13 B PHE 318 -99.62 37.03 13 B ASN 348 -156.67 -92.39 13 B TYR 349 34.17 -74.50 13 B THR 350 78.72 128.48 13 B PHE 366 -88.45 47.84 13 B GLN 369 -142.31 51.06 13 B PRO 381 -68.83 -158.72 14 A MET 7 -110.54 -140.87 14 B TYR 349 -157.49 -65.67 14 B THR 350 64.88 134.41 14 B LYS 367 -51.75 -79.78 14 B ASN 368 -82.87 38.81 14 B GLN 369 -149.89 49.42 15 A ASN 8 -123.42 -58.74 15 B GLN 297 -163.74 -25.47 15 B ASN 299 38.09 77.58 15 B GLN 300 47.27 167.97 15 B PHE 366 -88.80 48.41 15 B GLN 369 -142.46 53.57 15 B PRO 381 -76.00 -79.28 minimized average NMR STRUCTURE OF THE HUMAN MAD1 TRANSREPRESSION DOMAIN SID IN COMPLEX WITH MAMMALIAN SIN3A PAH2 DOMAIN 1 N N 2 N N A ILE 9 A ILE 4 HELX_P A GLU 20 A GLU 15 1 1 12 B VAL 302 B VAL 8 HELX_P B ARG 317 B ARG 23 1 2 16 B PRO 322 B PRO 28 HELX_P B ALA 345 B ALA 51 1 3 24 B GLU 355 B GLU 61 HELX_P B LEU 365 B LEU 71 1 4 11 B GLU 370 B GLU 76 HELX_P B GLY 377 B GLY 83 1 5 8 TRANSCRIPTION Four-helix bundle, Protein-peptide Complex, TRANSCRIPTION NP_002348 GB 1 6 4505069 RMNIQMLLEAADYLER SIN3A_MOUSE UNP 2 295 Q60520 SLQNNQPVEFNHAINYVNKIKNRFQGQPDIYKAFLEILHTYQKEQRNAKEAGGNYTPALTEQEVYAQVARLFKNQEDLLS EFGQFLPDA 6 21 1G1E 6 21 4505069 A 1 1 16 295 383 1G1E 295 383 Q60520 B 2 1 89 1 P 1